Cathie Wood’s ARK Invest (ARKK) deepened investment in AI chipmakers, gene-editing companies, and autonomous-driving developers while continuing to trim positions in Tesla (TSLA) and several mature tech companies and life sciences names.
In semiconductors, ARK increased positions in Advanced Micro Devices (AMD), Broadcom (AVGO) and Taiwan Semiconductor Manufacturing (TSM), signaling conviction in companies supplying infrastructure for AI workloads.
The investment firm continues to double down on next-generation sequencing and in vivo gene editing, even as it trims other life sciences names. It added 196K shares of Intellia Therapeutics (NTLA), 49K shares of 10x Genomics (TXG), 133K shares of GeneDx (WGS), and 17K shares of Personalis (PSNL).
Another sector of keen interest last week was autonomous trucking, robotaxis, and vehicle intelligence, reinforcing its long-term robotics scope. Major buys included WeRide (WRD), Pony AI (PONY), Kodiak Robotics (KDK), BYD Company (BYDDF), and Trimble (TRMB) across its ARK Autonomous Technology & Robotics ETF (ARKQ) and ARK Space & Defense Innovation ETF. Besides, the fund also bought shares of Oklo (OKLO), Klarna Group (KLAR), and Deere & Co. (DE).
On the selling side, ARK reduced holdings in Tesla (TSLA), selling over 86K shares worth above $37M. It also chopped ~$6.5M worth of holdings in Unity Software (U) and trimmed stakes in Teradyne (TER) and Kratos Defense & Security Solutions (KTOS).
Ark trimmed life science names, cutting diagnostics and legacy sequencing while reallocating to editing-first platforms. Ark cut stakes in Illumina (ILMN), Beam Therapeutics (BEAM), Ionis Pharmaceuticals (IONS) and Natera (NTRA). Other names where Ark pared back positions include Intuit (INTU) and Global‑E Online (GLBE).
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.